Meiner V L, Cases S, Myers H M, Sande E R, Bellosta S, Schambelan M, Pitas R E, McGuire J, Herz J, Farese R V
Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94110, USA.
Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):14041-6. doi: 10.1073/pnas.93.24.14041.
The microsomal enzyme acyl-CoA:cholesterol acyltransferase (ACAT; EC 2.3.1.26) catalyzes the esterification of cellular cholesterol with fatty acids to form cholesterol esters. ACAT activity is found in many tissues, including macrophages, the adrenal glands, and the liver. In macrophages, ACAT is thought to participate in foam cell formation and thereby to contribute to atherosclerotic lesion development. Disruption of the gene for ACAT (Acact) in mice resulted in decreased cholesterol esterification in ACAT-deficient fibroblasts and adrenal membranes, and markedly reduced cholesterol ester levels in adrenal glands and peritoneal macrophages; the latter finding will be useful in testing the role of ACAT and macrophage foam cell formation in atherosclerosis. In contrast, the livers of ACAT-deficient mice contained substantial amounts of cholesterol esters and exhibited no reduction in cholesterol esterification activity. These tissue-specific reductions in cholesterol esterification provide evidence that in mammals this process involves more than one form of esterification enzyme.
微粒体酶酰基辅酶A:胆固醇酰基转移酶(ACAT;EC 2.3.1.26)催化细胞内胆固醇与脂肪酸酯化形成胆固醇酯。ACAT活性存在于许多组织中,包括巨噬细胞、肾上腺和肝脏。在巨噬细胞中,ACAT被认为参与泡沫细胞形成,从而促进动脉粥样硬化病变发展。小鼠中ACAT基因(Acact)的破坏导致ACAT缺陷型成纤维细胞和肾上腺膜中胆固醇酯化减少,肾上腺和腹膜巨噬细胞中胆固醇酯水平显著降低;后一发现将有助于测试ACAT和巨噬细胞泡沫细胞形成在动脉粥样硬化中的作用。相反,ACAT缺陷型小鼠的肝脏含有大量胆固醇酯,且胆固醇酯化活性未降低。这些组织特异性的胆固醇酯化减少提供了证据,表明在哺乳动物中,这一过程涉及不止一种形式的酯化酶。